26 A novel assay to evaluate the response of patient-derived virus to latency-reversing agents ex vivo

• H. Lu,
• M. Moso,
• L. Gray,
• T. Mota,
• J. Jacobson,
• A. Ellett,
• W.-J. Cheng,
• D. Purcell,
• P. Cameron,
• M. Churchill,
• S. Lewin

Affiliations

H. Lu

Peter Doherty Institute, University of Melbourne, Melbourne, Australia

M. Moso

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; Monash University, Department of Infectious Diseases, Melbourne, Australia

L. Gray

Monash University, Department of Infectious Diseases, Melbourne, Australia; Burnet Institute, Centre for Biomedical Research, Melbourne, Australia

T. Mota

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; University of Melbourne, Microbiology and Immunology, Melbourne, Australia

J. Jacobson

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; University of Melbourne, Microbiology and Immunology, Melbourne, Australia

A. Ellett

Burnet Institute, Centre for Biomedical Research, Melbourne, Australia

W.-J. Cheng

Burnet Institute, Centre for Biomedical Research, Melbourne, Australia

D. Purcell

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; University of Melbourne, Microbiology and Immunology, Melbourne, Australia

P. Cameron

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; Monash University, Department of Infectious Diseases, Melbourne, Australia

M. Churchill

Monash University, Department of Infectious Diseases, Melbourne, Australia; Burnet Institute, Centre for Biomedical Research, Melbourne, Australia; Monash University, Department of Microbiology, Melbourne, Australia

S. Lewin

Peter Doherty Institute, University of Melbourne, Melbourne, Australia; Monash University, Department of Infectious Diseases, Melbourne, Australia